{"nctId":"NCT01394718","briefTitle":"Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients","startDateStruct":{"date":"2011-07"},"conditions":["Pain, Postoperative"],"count":67,"armGroups":[{"label":"Saline Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]},{"label":"Intravenous Acetaminophen","type":"EXPERIMENTAL","interventionNames":["Drug: Intravenous Acetaminophen"]}],"interventions":[{"name":"Intravenous Acetaminophen","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nSubjects 10-18 years who are status post anterior or posterior spine fusion surgery\n\nExclusion Criteria:\n\n1. All patients requiring mechanical ventilation post-operatively, continuous infusions of sedative, or continuous infusions of alternate opiates (i.e. fentanyl)\n2. Patients with hepatic dysfunction\n3. Patients with chronic opiate requirements\n4. Pregnant or lactating females\n5. Patients placed on opiates other than morphine or hydromorphone\n6. Patients with opiate or acetaminophen allergies\n7. Patients placed on alternate analgesic adjuncts (i.e. ketamine, etc)\n8. Patients who receive intrathecal opiates","healthyVolunteers":false,"sex":"ALL","minimumAge":"10 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Opiate Requirement","description":"Total opiate requirement was monitored 24 hours post-operatively. Morphine and hydromorphone measurements were totaled and recorded in mg/kg/day of morphine equivalents.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.19","spread":"0.43"},{"groupId":"OG001","value":"1.01","spread":"0.32"}]}]}]},{"type":"SECONDARY","title":"Average Pain Score","description":"Pain Scores were monitored using the numeric pain assessment scale in both treatment arms of the study and recorded and averaged for the first 24 hours after initial intra-operative dose of study drug. The numeric pain assessment scale is a verbal self-reported pain assessment that ranges between 1 (no pain) to 10 (worst pain imaginable).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.53","spread":"2.02"},{"groupId":"OG001","value":"4.62","spread":"1.99"}]}]}]},{"type":"SECONDARY","title":"Average Nausea Score","description":"Nausea scores were recorded by the nursing staff approximately 4 times over the first 24 hours and then averaged for the 24 hour period. Nausea Scores range from 1 (none) to 4 (severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":null},{"groupId":"OG001","value":"1.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Average Pruritus Score","description":"Pruritus scores were recorded by the nursing staff approximately 4 times over the first 24 hours and then averaged for the 24 hour period. Pruritus scores range from 1 (none) to 3 (intolerable).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":[]}}}